The invention discloses a pure Chinese herba preparation for treating
leukemia, which includes, by weight ratio, from 10 to 30 parts of
eucommia ulmoides, from 10 to 30 parts of
morinda officinalis, from 10 to 30 parts of
cistanche deserticola, from 10 to 30 parts of walnut kernels, from 5 to 10 parts of fennel, from 5 to 10 parts of
fructus psoraleae, from 5 to 15 parts of pericarpium zanthoxyli, from 10 to 30 parts of
astragalus mongholicus, from 10 to 20 parts of caulis spatholobi, from 5 to 15 parts of bighead atractylodes
rhizome, from 5 to 20 parts of
ligusticum wallichii, from 5 to 15 parts of
salvia miltiorrhiza, from 5 to 20 parts of radix
polygonum multiflorum preparata, from 5 to 20 parts of
grifola, from 5-15 parts of sculellaria barbata, from 5 to 15 parts of wolfberry fruits, from 5 to 15 parts of
codonopsis pilosula, from 5 to 15 parts of Chinese angelica, from 5 to 15 parts of
rehmannia glutinosa, from 5 to 15 parts of rhizoma polygonati, from 5 to 10 parts of
donkey-hide
gelatin, from 8 to 15 parts of
panax notoginseng powder, from 10 to 20 parts of dried longan pulp, from 5 to 20 parts of hawthorn, from 5 to 15 parts of Chinese fanpalm seeds, from 5 to 15 parts of
rohdea japonica, from 10 to 20 parts of glaucescent
fissistigma roots, from 30 to 50 parts of
ganoderma lucidum
spore powder, from 8 to 12 parts of fresh spirulina, from 8 to 12 parts of fresh alfalfa juice and from 4 to 6 parts of buddha-
fruit juice. The pure Chinese herba preparation treats the
leukemia by means of reinforcing
kidney, warming yang and invigorating qi and blood, and is remarkable in
curative effect and low in cost.